news
Automated insulin pumps fail to track menstrual cycle hormone shifts
Martina Rothenbühler from the Diabetes Center Berne presented clinical findings in Dresden showing how menstrual cycle phases alter insulin sensitivity in women with type 1 diabetes. Current automated insulin delivery algorithms and clinical guidelines still treat female metabolic needs as a static baseline. That leaves women managing unpredictable glucose spikes in the luteal phase without software support.
Martina Rothenbühler from the Diabetes Center Berne presented clinical findings in Dresden showing how menstrual cycle phases alter insulin sensitivity in women with type 1 diabetes. Current automated insulin delivery algorithms and clinical guidelines still treat female metabolic needs as a static baseline. That leaves women managing unpredictable glucose spikes in the luteal phase without software support.
The architecture take
Treating a female endocrine system like an unvarying 24-hour loop is lazy engineering, especially when you are selling automated medical tech. In the luteal phase, rising progesterone drives up systemic insulin resistance, often demanding up to 30 percent more insulin just to clear an identical lunch. Then estrogen drops, bleeding starts, and sensitivity snaps back fast, creating a sudden risk for sharp hypos. Commercial closed-loop pumps take days to adapt because their learning models assume yesterday looks like today. I find it wild that consumer rings can predict a bleed four days out from skin temperature alone, yet five-thousand-dollar prescription pumps still act surprised every twenty-eight days. Device makers will eventually have to build cycle tracking directly into their pump logic. Until then, women are left manually overriding algorithms that were trained on steady-state male physiology.